Skip to content

Active ingredient

Eribulin

17 finished FDA listings contain Eribulin as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
ERIBULIN, ERIBULIN MESYLATE
Dosage forms
Injection, Solution
Routes
Intravenous
Manufacturers / labelers
16
Strengths listed
.5 mg/ml · 1 mg/2ml
Brand names in FDA listings
Halaven

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 1045453

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 201532EISAI INC2010-11-152
ANDA 218047GLAND2024-04-053
ANDA 218281JIANGXI KVVIT PHARM2024-06-281
ANDA 214850LONG GROVE PHARMS2024-07-183
ANDA 217250BAXTER HLTHCARE CORP2024-10-011
ANDA 218743CHIA TAI TIANQING2025-03-042
ANDA 214310SANDOZ2025-06-091
ANDA 217473DR REDDYS2025-07-031
ANDA 218142GLENMARK PHARMS2025-08-052
ANDA 219054XGEN PHARMS2026-03-161

Official labeling on DailyMed

Showing the 12 most recent of 16 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.